Table 1

Clinical characteristics of the studied subjects.

Characteristics
Active CD
Non-active CD
Control

Number of patients
30
18
30
Age (average months and SD)
56.4 (38.5)
65.2 (37.7)
45.0 (33.5)
Gender



     - male
12/30 (40.0%)
8/18 (44.4%)
13/30 (43.3%)
     - female
18/30 (60.0%)
10/18 (55.6%)
17/30 (56.7%)
Clinical



     - Abdominal
2/30 (6.6%)
-
-
     - Diarrhoea
28/30 (93.4%)
2/18 (11.1%)
-
     - Weight loss
9/30 (30.0%)
-
-
     - Anaemia
14/30 (46.6%)
8/18 (44.4%)
-
Biochemical



     - Asymptomatic
4/30 (13.3%)
18/18 (100%)
-
     - Iron deficiency
10/30 (33.3%)
-
-
Serology



AGA (anti-gliadin antibodies)
AGA + (100%)
AGA + (0%)
AGA + (0%)
t-TG (anti-transglutaminase antibodies)
t-TG + (100%)
t-TG + (0%)
t-TG + (0%)
Duodenal Biopsy a
M3 (100%)
M0-1 (100%)
M0-1 (100%)

a Modified Marsh Classification of CD[18]. M0: Normal mucosa; CD highly unlikely. M01: (Infiltrative lesion): Seen in patients on a gluten-free diet (suggesting minimal amounts of gliadin are being ingested); patients with dermatitis herpetiformis (DH); and family members of patients with CD. M2 (Hyperplasic type): seen occasionally in DH. M3: > 40 Intraepithelial Lymphocytes per 100 Enterocytes, crypts increased and villi with atrophy (partial or complete villous atrophy).

Collado et al. BMC Microbiology 2008 8:232   doi:10.1186/1471-2180-8-232